MYX ASX · Health Care

Mayne Pharma Group Ltd

Announcements, last 12 months: 112
Price sensitive, last 12 months: 31
Followed on InvestorPA: Moderate (Among the 13% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
19 Oct 2026, 9:15 AM	2026 Notice of Annual General Meeting and shareholder pack
16 Oct 2026, 9:43 AM	MYX settles US patent litigation re Imvexxy with Teva USA Price sensitive	AI summary
14 Oct 2026, 1:29 PM	Supreme Court Decision in Cosette Proceedings Price sensitive	AI summary
14 Oct 2026, 8:20 AM	Trading Halt Price sensitive	AI summary
9 Oct 2026, 9:41 AM	Fulfilment of Imvexxy post-marketing study requirements
7 Oct 2026, 4:30 PM	Notification of cessation of securities - MYX
30 Sep 2026, 9:49 AM	MYX settles US patent litigation re Imvexxy with Sun Pharma Price sensitive	AI summary
28 Sep 2026, 9:45 AM	Mayne Pharma announces legal settlement
28 Sep 2026, 9:42 AM	Date for Annual General Meeting
15 Sep 2026, 9:50 AM	MYX signs licence agreement for Blissel in Australia

Sign in to see all MYX announcements.

Guidance history

27 Aug 2026	FY26 revenue: $383.7 million; Gross margin: 64.7%; Underlying EBITDA: $34.2 million
27 Aug 2026	FY27 expected to see continued margin expansion and commercial momentum
31 Jul 2026	FY26 revenue: $383.7 million; FY26 gross margin: 65%; FY26 underlying EBITDA: $31.7 million

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow MYX to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.